Dr. Avyakta Kallam, MD

Avyakta Kallam, MDkallam_propic.jpg
Assistant Professor, Internal Medicine
Division of Oncology & Hematology

Academic office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax 402-559-6520

Practice locations:
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

Bellevue Medical Center Cancer Clinic
2500 Bellevue Medical Center Dr., Suite 250
Bellevue, NE 68123 (map)

Nebraska Medicine Village Pointe
111 North 175th Street
Omaha, NE 68118 (map)

Education:
Osmania Medical College, Hyderabad, India, (2009)
Creighton University School of Medicine, Omaha, NE Internal Medicine Residency, (2014)
Creighton University School of Medicine, Omaha, NE, Chief Resident, (2015)
University of Nebraska Medical Center, Omaha, NE, Fellowship in Medical Oncology and Hematology, (2018)

Hospital Appointments:
Nebraska Medicine

Interests:
Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Early Phase Clinical Trials

Biographical Sketch:
Dr. Avyakta Kallam is an Assistant Professor in the Department of Internal Medicine, Division of Hematology/Oncology. She received her her medical degree from Osmania Medical College, Hyderabad, India. She then went on to do internal medicine residency at Creighton University Medical Center in Omaha, NE. Following this, she worked as a Chief Resident in Internal Medicine at Creighton University Medical Center and VA Medical Center. She then joined the University Of Nebraska Medical Center in Omaha, Nebraska and completed her fellowship in Medical Oncology and Hematology.

She has authored or co-authored numerous articles, book chapters and abstracts. She has also presented her research at several national and international meetings and was awarded the American Society of Hematology abstract achievement award in 2017. She has also served as an expert reviewer for a number of scientific journals. She is currently involved in clinical research related to lymphoid malignancies and phase I clinical trials.

Selected Publications:

Kallam A., Armitage JO., Venetoclax in chronic lymphocytic leukaemia: a possible cure? The Lancet Oncology 19:9, P1143-1144. doi:https://doi.org/10.1016/S1470-2045(18)30442-X (2018)

Kommalapati A., Kallam A., Krishnamurthy J., et al. Upper Limb Phlegmasia Cerulea Dolens Secondary to Heparin-induced Thrombocytopenia Leading to Gangrene. Cureus 10(6): e2853. doi:10.7759/cureus.2853. (2018)

Kallam A., Armitage JO., Current and emerging treatment options for a patient with a second relapse of Hodgkin’s lymphoma, Expert Review of Hematology, 11:4, 293-300, DOI: 10.1080/17474086.2018.1449637 (2018)

Rana S., Holland J., Marquez C., Kallam A., Armitage JO., Sanghvi P. Gray Zone Coping with Knife: Post-operative management of nodular lymphocyte predominant Hodgkin Lymphoma. International Journal of Radiation Oncology. Biology • Physics (2017), doi: 10.1016/ j. ijrobp.2017.10.043.

Kallam A., Ganti AK., Bevacizumab in extensive disease small cell lung cancer: the search continues. Transitional cancer research. Volume 6, supplement 3. (2017)

Kallam A., Bierman PJ., Bociek RG. Kikuchi’s Disease Masquerading as Refractory Lymphoma. Journal of Oncology Practice 12 (1), 94-96. (2016)

Tandra P., Kallam A., Guduru M., Bendi VS., Krishnamurthy J, Bierman P., Paraneoplastic Manifestations of Lymphoproliferative Neoplasms. Lymphoma and Chronic Lymphocytic Leukemias 6, 21. (2016)

Kallam A., Armitage JO, Chen B., Vose JM., Bhatt VR., Center Effect and Socioeconomic Determinants of Overall Survival (OS) of Diffuse Large B Cell Lymphoma (DLBCL). Blood 128 (22), 5949-5949. (2016)

Umakanthan JM., Maness L., Luo J., Kallam A., Armitage JO., Bierman PJ., Vose JM., Bociek RG., Lunning M., Gundabolu K., Bhatt VR., Safety and Efficacy of Enoxaparin Prophylaxis in Adults Receiving Peg-Asparaginase Containing Induction Regimens for Acute Lymphoblastic Leukemia (ALL). Blood 128 (22), 5154-5154. (2016)

Kallam A., Alsop B., Sharma P., Limitations of ablation therapy in Barrett’s Esophagus. Expert review of gastroenterology & hepatology 9 (4), 487-496. (2015)

Kallam A., Singla A., Silberstein P. Pantoprazole induced thrombocytopenia: Case report and review of literature, Platelets 26 (6), 598-601. (2015)

Kallam A., Krishnamurthy J., Shonka N. A case of alveolar rhabdomyosarcoma. Rare tumors 7 (4) (Case report and review of literature). (2015)

Kallam A., Meyerink K., & Modrykamien AM. Physician-Ordered Aerosol Therapy Versus Respiratory Therapist-Driven Aerosol Protocol: The Effect on Resource Utilization. Respiratory care, 58(3), 431-437. (2013)

Bhatt V.R., Kallam A., Silberstein P., Wang J The Initial and Subsequent Lines of Systemic Therapy for Metastatic Renal Cell Carcinoma: Practical Considerations. Federal Practitioner, 30(5),43S-47S. (2013)

Additional Publications at PubMed.Gov: https://www.ncbi.nlm.nih.gov/pubmed